Follow us on:
Breaking News
February 25, 2026
Breaking News
Breaking News
LabVantage_eBook_1025_650x90

AbbVie to Build New API Manufacturing Facilities in North Chicago

 
AbbVie to Build New API Manufacturing Facilities in North Chicago

Announces a $380 billion investment to support the production of AbbVie's next-gen neuroscience and obesity medications.
Read More >>

Headlines

Breaking News

Flamma USA Successfully Passes FDA Inspection

PAI took place over four days for an API that the Malvern, PA site will manufacture for a global pharma company.

SPONSOR

[LIVE EVENT] The Tech Transfer Roundtable: Real World Lessons from Rentschler Biopharma’s Experts

In this panel discussion on February 26th, Rentschler Biopharma’s experts share real‑world lessons from supporting complex programs through phase‑appropriate development, scale‑up, and cGMP manufacturing.

Breaking News

Avid Bioservices Opens Early Phase Center of Excellence in CA

Expands Avid's development footprint and strengthens its ability to provide end-to-end services from cell line development through commercial manufacturing.

Breaking News
Collaborations & Alliances

Astellas Pharma, Vir Biotechnology Partner to Advance VIR-5500

VIR-5500 is an investigational PRO-XTEN dual-masked CD3 T-cell engager (TCE) targeting PSMA for the treatment of prostate cancer.

SPONSOR

[eBook] Integrated Excellence: A Unified Approach To Development, Manufacturing, Testing, And Storage

As drug development grows increasingly complex, pharma and biotech teams are seeking partners with the scientific depth and agility to keep pace.

Breaking News

Clinilabs Expands European Operations

Establishes EU headquarters in Switzerland and appoints executive vice president and head of Clinilabs Europe.

SPONSOR

Next-Generation Topical Approach: A Breakthrough in Liposome-Integrated Formulations

Topical delivery is evolving. Discover how liposome-integrated formulations enhance penetration, retention & therapeutic effect.

Featured Resources

Solution Content Centers SPOTLIGHT

Sentry BioPharma Services, Inc.

Sentry BioPharma Services, Inc. (Sentry US) protects product SISPQ by offering compliant pharmaceutical services, including cGMP temperature-controlled storage, controlled substance management (CS III-V), clinical/commercial labeling and secondary packaging. Sentry also provides import/export optimization by leveraging our end-to-end GxP logistics, global distribution and Foreign Trade Zone expertise. Sentry’s status as a US Foreign Trade Zone enables products from outside the United States to be received and held within cGMP storage, pending approval for importation from the FDA, CBP and DEA. Sentry is VAWD accredited, licensed in all US states and inspected by the FDA, along with numerous international authorities. Sentry’s newest facility in Columbus, IN provides stock splitting risk mitigation services and will offer additional cGMP offerings in 2026.

 

Solution Content Centers SPOTLIGHT

Praxis Packaging Solutions

Contract packaging demands flexibility, efficiency, and control. At Praxis, we deliver all three through the innovative, cost effective application of manual labor and the skillful use of automated and custom packaging equipment. We've been doing so for about a quarter century. Our OTC/Rx pharmaceutical, consumer products, and medical device customers choose us for four reasons: a relentless focus on compliance, astonishing speed-to-market, unyielding accountability, and significant category experience. At Praxis, we don't just deliver innovative, turnkey packaging solutions. We provide them while exceeding our customers' expectations, while managing their critical deadlines, and while upholding rigorous regulatory and quality standards. You could call it agility; we call it Managed Rapid Response, and here at Praxis, it's at the heart of what we do. Upholding standards is so deeply engrained at Praxis that, since the company was formed, we've had exactly zero recalls.